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Successful hybrid operation of an acute mobile 
thrombus in the abdominal aorta induced by 
chemotherapy
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Acute mobile thrombus of the abdominal aorta after chemotherapy is a very unusual finding, which can be a potential source 
of arterial embolism. We report here on a case of an acute mobile aortic thrombus with renal infarction. We successfully treat-
ed the patient with hybrid operation-open surgical and endovascular approach. Our case shows that hybrid treatment using 
wire-directed balloon catheter thrombectomy is a feasible, minimally-invasive treatment for a mobile aortic thrombus. 
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INTRODUCTION
A mobile aortic thrombus in a non-atherosclerotic, 
non-aneurysmal aorta and is not a common finding [1]. A 
mobile aortic thrombus is a potential source of visceral, 
cerebral and peripheral embolism [1]. The management of 
a mobile aortic thrombus is not well established because of 
its rare occurrence [1]. Yet treatment is mandatory because 
of the potential risk for recurrent embolization. Manage-
ment of a mobile aortic thrombus includes systemic anti-
coagulation, aortic thromboendarterectomy or covered 
stenting. Here we describe a case of acute mobile aortic 
thrombus with renal infarction, which was successfully 
treated with hybrid surgery using wire-directed balloon 
catheter thrombectomy.
CASE REPORT 
A 44-year-old woman was diagnosed with advanced 
gastric cancer (T4N3) for which total gastrectomy was 
performed. Twelve days after the operation, adjuvant che-
motherapy was started with cisplatin and 5-fluorouracil. 
She received cisplatin (92 mg/day for 4 days) and 5-fluo-
rouracil (1,530 mg/day for 1 day). Two days after the 1st 
chemotherapy, the patient presented with a sudden onset 
of right flank pain and dizziness. Emergency computed 
tomography (CT) imaging of her abdomen and pelvis was 
performed. A large thrombus was identified in the ab-
dominal aorta at the origin of the renal arteries, and it in-
volved the right renal artery causing renal infarction (Fig. 
1). The CT scan prior to the chemotherapy showed a nor-Hybrid operation for acute aortic thrombus
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Fig. 1. Abdominal computed tomography shows intraluminal 
aortic thrombus (arrow) with infarction of the right kidney.
Fig. 2. Angiogram shows occlusion balloons in the left iliac artery 
(thin arrow) and in the left renal artery (thick arrow).  Abdominal 
aortic thrombus is shown as by intraluminal filling defect (open 
arrow).
mal aorta at the origin of the renal arteries. Chest X-rays 
showed no abnormality. The electrocardiography and 
echocardiogram excluded arrhythmia or intracardiac 
thrombi. Initial laboratory findings were within normal 
limits; prothrombin time international normalized ratio 
1.01, activated partial thromboplastin time 33.7 seconds, 
protein C activity 125%, antithrombin III 108%, blood urea 
nitrogen 13.8 mg/dL, creatinine 0.74 mg/dL, except for 
protein S activity 56%. Only protein S activity was lower 
than the normal limit (71 to 103%). A therapeutic intra-
venous infusion of unfractionated heparin was com-
menced. To minimize surgical burden to the patient who 
was on her 17th day after major surgery, hybrid surgery 
was chosen. Hybrid treatment was performed under gen-
eral anesthesia. A transbrachial aortic angiogram was per-
formed, which revealed a large filling defect in the aorta 
just at the origin of the renal arteries and there was no flow 
to the right renal artery. A cut-down of the right common 
femoral artery and a puncture of the left common femoral 
artery were performed. After gaining percutaneous ac-
cess, a 10 × 40 mm balloon (ev3 Inc., Plymouth, MN, USA) 
was placed to occlude the left iliac artery to prevent con-
tralateral embolization. And then, a 5  × 20 mm balloon 
(Cordis Co., Miami Lakes, FL, USA) was used to occlude 
the left renal artery (Fig. 2). Thereby, we could avoid renal 
artery embolization and contralateral groin cut down. 
Wire-directed balloon catheter thrombectomy was per-
formed using a 5F over-the-wire Fogarty catheter 
(LeMaitre Vascular Inc., Burlington, MA, USA) via the 
right femoral access. An angiogram after thrombectomy 
revealed a residual filling defect in the aorta. The aortic 
thrombus was macerated using a Trerotola mechanical 
thrombectomy device (Arrow International Inc., Reading, 
PA, USA). A wire-directed balloon catheter thrombectomy 
was then performed using a 27 mm Equalizer balloon 
catheter (Boston Scientific, Cork, Ireland, USA). The com-
pletion angiogram demonstrated no residual thrombus 
with no embolus in the left renal artery or in the bilateral 
lower extremity arterial systems (Fig. 3). Left renal balloon 
occlusion was maintained for 41 seconds and the left kid-
ney function was preserved after reperfusion. We used 
about 150 mL of contrast media (VISIPAQUE Injection, 270 
mgI/mL; Amersham health, Cork, Ireland) and the post-
operative creatinine level was 0.98 mg/dL. Chemotherapy 
was stopped after thrombectomy and the patient received 
systemic heparinization for 1 week and then received anti-
platelets including aspirin, cilostazol, and atorvastatin cal-
cium, indefinitely. Follow- up CT scan 7 days after the pro-
cedure showed complete resolution of the thrombus (Fig. 
4). Eighteen days after the procedure, chemotherapy was 
restarted with only 5-fluorouracil, because cisplatin has 
renal toxicity and can cause another thrombus. After 5- 
months follow-up, she is doing well without another aort-
ic thrombus.Woo Chul Kim, et al.
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Fig. 3. After balloon catheter thrombectomy, angiogram shows 
successful removal of the aortic thrombus.
Fig. 4. Follow-up computed tomography on 7 days after balloon 
catheter thrombectomy, shows complete resolution of the aortic 
thrombus. Right renal artery is partially recannalized.
DISCUSSION
Mobile aortic thrombus is a rare pathology and is an im-
portant source of arterial emboli. Mobile aortic thrombus 
mostly occurs in the distal aortic arch in the presence of se-
vere diffuse atherosclerotic disease and has been reported 
in hypercoagulable patients [2]. In our case, however, the 
mobile aortic thrombus is thought to have developed due 
to the chemotherapy as there was no evidence of athero-
sclerotic disease, aneurysmal dilatation of the aorta. 
Because protein S activity was diminished, there is the 
possibility of protein S deficiency. But protein S deficiency 
usually manifests clinically as venous thromboembolism. 
Arterial thrombosis is not evident with protein S defi-
ciency [3].
Chemotherapy agents have been documented as possi-
ble causes of acute arterial thrombosis  Licciardello et al. 
[4] reported that cisplatin induced increase in the von 
Willebrand factor concentration, which increases the risk 
of arterial occlusive complications. So they emphasized 
monitoring the von Willebrand factor concentration be-
fore starting chemotherapy. Unfortunately, the von 
Willebrand factor concentrations in this patient were not 
investigated before chemotherapy.
While there are increasing number of reports on thor-
acoabdominal aortic thrombus as a cause of embolism, the 
optimal treatment is remains controversial [5]. Systemic 
anticoagulation, aortic thromboendarterectomy or place-
ment of stent graft were reported as treatments of a mobile 
aortic thrombus [5-8]. Complete disappearance or a reduc-
tion in the size of the thrombus has been reported with the 
use of anticoagulation alone [6]. Kim et al. [5] suggested a 
strategy beginning with low molecular weight heparin as 
the first line of treatment, followed by surgical thrombus 
removal if the thrombus persists or recurrent embolism 
occurs during anticoagulation therapy. In contrast, other 
investigators have recommended an aggressive surgical 
approach using aortic thromboendarterectomy [1,7]. The 
management of mobile aortic thrombus is not well estab-
lished because of its rarity, and there are few comparative 
studies. Recently, some cases were reported in the liter-
atures that support the endovascular approach of aortic 
thrombus [8]. They attempted to manage mobile throm-
bus of the thoracic aorta with endovascular approach, spe-
cifically with stent graft, and showed successful results [8]. 
However, our case could not be treated with a covered 
stent because the aortic thrombus was in the aorta right at 
the origin of the renal arteries. So, we performed throm-
bectomy using a wire-directed balloon catheter with oc-
clusion balloons. Another method to prevent distal embo-
lization is using a filter [9], which was not available in our 
institution. In our case, a 5F Fogarty catheter was useless 
for thrombectomy. The aortic thrombus adhered to the 
wall firm enough to resist the thrombectomy balloon. 
Therefore, we used a mechanical thrombectomy device for 
maceration of the aortic thrombus; Trerotola device Hybrid operation for acute aortic thrombus
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(Arrow International Inc.) with a 5F rotating nitinol basket 
fragmentation cage. We intended the wires of the basket 
directly contact the thrombus, not injuring the aortic wall, 
and we carefully performed maceration of the aortic 
thrombus. Yet, it has risks of peripheral embolization of 
the clot particles and vessel wall injury. 
Because of the irreversible infarction of the right kidney 
at more than 29 hours, we did not perform wire-directed 
thrombectomy for the right renal thrombus. In our case, 
chemotherapy was discontinued after hybrid treatment 
and the patient took systemic heparinization for 1week, 
then oral antiplatelets. Antiplatelets have a proven effi-
cacy in acute treatment and prevention of arterial throm-
bosis because a thrombus that forms in arteries are rich in 
platelets, as opposed to a fibrin-rich thrombus that forms 
in veins [10].
In conclusion, we report here on the successful treat-
ment of a mobile abdominal aortic thrombus by hybrid 
treatment performing balloon catheter thrombectomy. 
Our case shows that this technique is a feasible, minimally 
invasive treatment for a symptomatic mobile abdominal 
aortic thrombus.  
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article 
was reported.
ACKNOWLEDGEMENTS
This work was supported by an Inha University Re-
search Grant.
REFERENCES
1. Kalangos A, Baldovinos A, Vuille C, Montessuit M, 
Faidutti B. Floating thrombus in the ascending aorta: a rare 
cause of peripheral emboli. J Vasc Surg 1997;26:150-4.
2. Tunick PA, Lackner H, Katz ES, Culliford AT, Giangola G, 
Kronzon I. Multiple emboli from a large aortic arch throm-
bus in a patient with thrombotic diathesis. Am Heart J 
1992;124:239-41.
3. ten Kate MK, van der Meer J. Protein S deficiency: a clinical 
perspective. Haemophilia 2008;14:1222-8.
4. Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK. 
Elevated plasma von Willebrand factor levels and arterial 
occlusive complications associated with cisplatin-based 
chemotherapy. Oncology 1985;42:296-300. 
5. Kim SD, Hwang JK, Lee JH, Cho HJ, Sung GY, Moon IS, et 
al. Free floating thrombus of the aorta: an unusual cause of 
peripheral embolization. J Korean Surg Soc 2011;80:204-11.
6. Choukroun EM, Labrousse LM, Madonna FP, Deville C. 
Mobile thrombus of the thoracic aorta: diagnosis and treat-
ment in 9 cases. Ann Vasc Surg 2002;16:714-22.
7. Lozano P, Gomez FT, Julia J, M-Rimbau E, Garcia F. 
Recurrent embolism caused by floating thrombus in the 
thoracic aorta. Ann Vasc Surg 1998;12:609-11.
8. Zhang WW, Abou-Zamzam AM, Hashisho M, Killeen JD, 
Bianchi C, Teruya TH. Staged endovascular stent grafts for 
concurrent mobile/ulcerated thrombi of thoracic and ab-
dominal aorta causing recurrent spontaneous distal 
embolization. J Vasc Surg 2008;47:193-6.
9. Shammas NW, Dippel EJ, Coiner D, Shammas GA, Jerin M, 
Kumar A. Preventing lower extremity distal embolization 
using embolic filter protection: results of the PROTECT 
registry. J Endovasc Ther 2008;15:270-6.
10. Mackman N. Triggers, targets and treatments for 
thrombosis. Nature 2008;451:914-8.